Acadian Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.39M Buy
1,163,785
+233,556
+25% +$880K 0.01% 621
2025
Q1
$4.21M Buy
930,229
+437,536
+89% +$1.98M 0.01% 551
2024
Q4
$3.48M Buy
492,693
+15,426
+3% +$109K 0.01% 621
2024
Q3
$3.88M Sell
477,267
-256,990
-35% -$2.09M 0.01% 565
2024
Q2
$4.69M Buy
734,257
+9,697
+1% +$61.9K 0.01% 517
2024
Q1
$5.45M Buy
724,560
+200,494
+38% +$1.51M 0.02% 449
2023
Q4
$4.85M Buy
524,066
+358,670
+217% +$3.32M 0.02% 467
2023
Q3
$1.67M Sell
165,396
-157,603
-49% -$1.59M 0.01% 739
2023
Q2
$4.03M Buy
322,999
+184,175
+133% +$2.3M 0.02% 506
2023
Q1
$1.62M Buy
138,824
+59,435
+75% +$691K 0.01% 767
2022
Q4
$842K Buy
+79,389
New +$842K ﹤0.01% 892